|
MID1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.518140E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.584100E-02 |
| Normal-vs-Stage2 |
3.224400E-01 |
| Normal-vs-Stage3 |
1.177430E-01 |
| Normal-vs-Stage4 |
2.736000E-01 |
| Stage1-vs-Stage2 |
6.858400E-01 |
| Stage1-vs-Stage3 |
5.689000E-01 |
| Stage1-vs-Stage4 |
3.560200E-01 |
| Stage2-vs-Stage3 |
9.494800E-01 |
| Stage2-vs-Stage4 |
7.782400E-01 |
| Stage3-vs-Stage4 |
6.531200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.004000E-03 |
| Normal-vs-AfricanAmerican |
3.550000E-02 |
| Normal-vs-Asian |
6.417800E-01 |
| Caucasian-vs-AfricanAmerican |
5.103000E-01 |
| Caucasian-vs-Asian |
6.557600E-01 |
| AfricanAmerican-vs-Asian |
2.262600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.848000E-01 |
| Normal-vs-Female |
2.91669999996635E-06 |
| Male-vs-Female |
3.66150000000731E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.789900E-02 |
| Normal-vs-Extreme_Weight |
3.975400E-01 |
| Normal-vs-Obese |
2.424400E-02 |
| Normal-vs-Extreme_Obese |
5.465000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.793410E-01 |
| Normal_Weight-vs-Obese |
8.308200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.255400E-01 |
| Extreme_Weight-vs-Obese |
1.249590E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.543000E-01 |
| Obese-vs-Extreme_Obese |
6.370600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.674300E-02 |
| Normal-vs-Age(41-60Yrs) |
8.425800E-04 |
| Normal-vs-Age(61-80Yrs) |
9.048500E-02 |
| Normal-vs-Age(81-100Yrs) |
9.887700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.242800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.361700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.831600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.365370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.239650E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.861800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.115670E-02 |
| Normal-VS-Type2 PRCC |
4.562200E-01 |
| Normal-VS-KIRP CIMP |
1.453160E-01 |
| Normal-VS-Unclassified PRCC |
4.050000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.812800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.801600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.623800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.041200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.072600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.132800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.836000E-01 |
| Normal-vs-N1 |
3.177800E-02 |
| Normal-vs-N2 |
8.090200E-02 |
| N0-vs-N1 |
1.413800E-01 |
| N0-vs-N2 |
1.295680E-02 |
| N1-vs-N2 |
1.370650E-01 |
|
|
